Technology
AI Transformations in the Epedigree Software Market, Projected USD 4.02 Billion Growth (2024-2028) Driven by Rising Demand for Serializability to Combat Counterfeiting – Technavio Report
Published
2 years agoon
By
NEW YORK, Aug. 23, 2024 /PRNewswire/ — The global epedigree software market size is estimated to grow by USD 4.02 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of 18.69% during the forecast period. Rising requirements for serializability to tackle counterfeiting is driving market growth, with a trend towards high-tech developments to smarten pharma supply chain. However, huge time and cost requirements for infrastructural implementation poses a challenge. Key market players include Altair Engineering Inc., ANSYS Inc., Antares Vision S.p.A, Aptean Group of Companies, Axway Software SA, Bar Code Integrators Inc., Blue Yonder Inc., Labeling Systems LLC, Merit Solutions Inc., Microsoft Corp., Optel Group, Oracle Corp., rfxcel Corp., SAP SE, Siemens AG, and TraceLink Inc..
Get a detailed analysis on regions, market segments, customer landscape, and companies- View the snapshot of this report
Epedigree Software Market Scope
Report Coverage
Details
Base year
2023
Historic period
2018 – 2022
Forecast period
2024-2028
Growth momentum & CAGR
Accelerate at a CAGR of 18.69%
Market growth 2024-2028
USD 4023.9 million
Market structure
Fragmented
YoY growth 2022-2023 (%)
16.01
Regional analysis
North America, Europe, APAC, South America, and Middle East and Africa
Performing market contribution
North America at 37%
Key countries
US, Germany, Japan, France, and China
Key companies profiled
Altair Engineering Inc., ANSYS Inc., Antares Vision S.p.A, Aptean Group of Companies, Axway Software SA, Bar Code Integrators Inc., Blue Yonder Inc., Labeling Systems LLC, Merit Solutions Inc., Microsoft Corp., Optel Group, Oracle Corp., rfxcel Corp., SAP SE, Siemens AG, and TraceLink Inc.
Market Driver
The global pharma industry faces a significant challenge with the proliferation of counterfeit drugs, estimated to be worth billions of dollars. This issue persists due to the intricate pharmaceutical supply chain, which lacks adequate quality control. Forgeries, drug redirection, and other related concerns are on the rise, posing a threat to consumer trust and the industry’s integrity. The pharma industry itself suffers from substantial losses due to the counterfeit market. To address these challenges, ePedigree software has emerged as a crucial solution. Serialization enables stakeholders to take a data-driven approach to inventory network trustworthiness and readiness. Advanced technologies like cloud computing, blockchain, and IoT are expected to revolutionize the pharma supply chain, enhancing efficiency and combating counterfeit drugs. The implementation of real-time product tracking and advanced analytics will streamline business procedures and ensure unit-level tracking. Innovations such as RFID technology, barcode scanners, and tag printers will support the adoption of cutting-edge systems across the pharma production and supply chain network. The expansion of cloud-based network capacities will facilitate extended visibility and collaboration between stakeholders. IoT, in conjunction with analytics, can aid in drug processing from manufacturing to distribution, optimizing stock management and reducing costs. The integration of high-tech developments into the pharma supply chain is fueling the growth of the global ePedigree software market.
The ePedigree software market is experiencing significant growth due to the increasing demand for drug authentication and supply chain security in the pharmaceutical industry. This software helps ensure the authenticity of pharmaceutical products by tracking and verifying their pedigree throughout the supply chain. With the rise of contaminated medicine and counterfeit drugs, ePedigree software has become essential for hospital pharmacies, retail pharmacies, pharmaceutical factories, online pharmacies, and more. Advanced technologies like smart devices, barcodes, cloud computing, and machine learning are driving innovation in the ePedigree software market. Serializability, counterfeiting prevention, and stock management are key features that make ePedigree software an indispensable tool for pharmaceutical businesses. Cloud-based solutions and blockchain technology offer scalability, security, and cost savings, making them popular choices for IT resources in the industry. EPedigree software also offers advanced analytics, big data, virtual assistants, augmented reality (AR), and virtual reality (VR) to enhance supply chain management and improve patient safety. By reducing wastage of products and improving inventory maintenance, ePedigree software helps pharmaceutical businesses save on healthcare expenditures and improve drug safety. Overall, the ePedigree software market is poised for continued growth as it addresses the critical need for advanced technologies in the pharma supply chain.
Explore a 360° Analysis of the Market: Unveil the Impact of AI. For complete insights- Request Sample!
Market Challenges
The ePedigree software market faces significant challenges due to the high cost and time requirements for implementation. The process begins with analyzing regulatory environments and organizational capabilities, followed by customizing vendor solutions for compliance. These steps increase the total implementation cost, which includes hardware and software systems. Preparing packaging lines for serialization necessitates substantial investments and a lengthy time frame. Transitioning from lot management to unit-level serialization is complex due to the heterogeneous supply chain systems. Customization for diverse regulatory requirements and organizational settings adds to the implementation cost. For instance, in the US and Europe, different regulatory standards exist, requiring unique implementation approaches. In the US, ePedigree is updated when custody changes, while Europe uses a centralized national database. Delayed regulatory deadlines in various regions further hinder market growth due to the intricate adoption process, extended implementation cycle, and the need to integrate ePedigree software with existing infrastructure across organizations and supply chains.The ePedigree software market is experiencing significant growth due to the increasing demand for advanced technologies in the pharmaceutical industry. Challenges such as machine learning for predictive analysis, virtual reality for training, and inventory management for stock control are being addressed through innovative solutions. Wastage of products and storage of drugs are major concerns, leading to the adoption of cloud-based and on-premises solutions, including blockchain technology. Hospital pharmacies, retail pharmacies, pharmaceutical factories, online pharmacies, biotechnology firms, medical devices sector, food and beverage, and cosmetics industries are investing heavily in healthcare IT to ensure drug pedigree, serialization, and patient safety. Advanced technologies like machine learning, Internet of Things, and track-and-trace solutions are revolutionizing supply chain management. Scalability and flexibility are crucial factors in choosing between cloud-based and on-premises solutions. Drug safety, hardware, IT resources, and blockchain are key areas of focus for reducing healthcare expenditures and ensuring drug safety.
For more insights on driver and challenges – Request a sample report!
Segment Overview
This epedigree software market report extensively covers market segmentation by
Deployment 1.1 On-premises1.2 CloudEnd-user 2.1 Large enterprise2.2 Small and medium enterprisesGeography 3.1 North America3.2 Europe3.3 APAC3.4 South America3.5 Middle East and Africa
1.1 On-premises- On-premises deployment of ePedigree software refers to installing and managing the software within an organization’s own infrastructure. This approach offers several advantages, including greater control, security, and customization. In regulated industries like pharmaceuticals, data security and regulatory compliance are top priorities. On-premises deployment enables companies to maintain full control over their data and ensure adherence to regulations. Additionally, on-premises deployment allows for greater flexibility in customization and integration with existing systems. While there are upfront investment and maintenance requirements, the control, security, and customization capabilities make on-premises deployment a preferred choice for many organizations in the global ePedigree software market.
For more information on market segmentation with geographical analysis including forecast (2024-2028) and historic data (2017-2021) – Download a Sample Report
Research Analysis
The ePedigree software market is experiencing significant growth due to the increasing demand for drug authentication and supply chain security in the pharmaceutical industry. EPedigree software refers to a system that ensures the authenticity, safety, and traceability of pharmaceutical products throughout the supply chain. This software utilizes various advanced technologies such as smart devices, serializability, barcodes, machine learning, Internet of Things, cloud computing, and advanced analytics. The primary goal is to prevent the circulation of contaminated medicine and counterfeit drugs, thereby enhancing patient safety. The market is expected to grow exponentially as the importance of secure and transparent pharmaceutical supply chains continues to increase. Virtual assistants and blockchain technology are also being integrated into ePedigree software to streamline processes and improve efficiency.
Market Research Overview
The ePedigree software market is a rapidly growing segment in the pharmaceutical industry, focused on ensuring the authenticity and safety of pharmaceutical products. This software plays a crucial role in combating the prevalent issues of contaminated medicine and counterfeit drugs by implementing smart devices, serializability, and advanced technologies such as barcodes, cloud computing, and machine learning. The pharma supply chain benefits significantly from ePedigree solutions through improved stock management, inventory maintenance, and wastage reduction. The market encompasses various sectors, including hospital pharmacies, retail pharmacies, pharmaceutical factories, online pharmacies, and biotechnology firms in the medical devices sector, food and beverage, and cosmetics industries. EPedigree software solutions offer scalability, flexibility, and cost-effective cloud-based and on-premises options. With the integration of advanced technologies like blockchain, Internet of Things, advanced analytics, big data, virtual assistants, augmented reality (AR), and virtual reality (VR), ePedigree software is revolutionizing healthcare IT investments and enhancing patient safety and drug safety.
Table of Contents:
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation
DeploymentOn-premisesCloudEnd-userLarge EnterpriseSmall And Medium EnterprisesGeographyNorth AmericaEuropeAPACSouth AmericaMiddle East And Africa
7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Trends
10 Company Landscape
11 Company Analysis
12 Appendix
About Technavio
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
View original content to download multimedia:https://www.prnewswire.com/news-releases/ai-transformations-in-the-epedigree-software-market-projected-usd-4-02-billion-growth-2024-2028-driven-by-rising-demand-for-serializability-to-combat-counterfeiting—technavio-report-302229589.html
SOURCE Technavio
You may like
Technology
Best AI Tools for Marketing Content (2026): CapCut Recognized for Faster AI-Powered Video and Image Creation by Better Business Advice
Published
13 minutes agoon
October 24, 2026By
NEW YORK, Oct. 24, 2026 /PRNewswire/ — Better Business Advice has recognized CapCut in its 2026 coverage of the best AI tools for marketing content, highlighting its collection of AI-powered features for creating and editing videos, images, audio, and other campaign assets. The recognition reflects growing interest in tools that help transform creative concepts into usable marketing materials while reducing the manual work involved in production.
Best AI Marketing Tools
Seedance 2.0 – an AI video generation model that creates videos from text prompts or imagesSeedream – an AI image generation model that creates high-quality visuals from text prompts
AI-powered content creation is changing how businesses develop digital marketing campaigns. From promotional videos and product imagery to social media graphics and branded audio, organizations face growing demand for creative assets across multiple digital channels. Tools that simplify production and support faster experimentation are becoming an increasingly important part of modern marketing workflows.
CapCut offers a range of AI-assisted capabilities covering several stages of content creation. These include text-based video generation, AI image generation, background removal, image expansion, music generation, and photo animation. Together, the tools provide options for producing marketing assets for social media, digital advertising, product promotions, and other online campaigns.
AI Video Generation Supports Promotional Campaigns
Video is an important format for communicating product information, presenting services, and building audience engagement. However, producing video content regularly can require significant planning, editing, and creative resources.
CapCut’s Seedance 2.0 AI video generator supports prompt-based video creation. Users can describe a creative concept and generate video content that serves as a starting point for further development.
The capability can support promotional videos, product showcases, educational content, and social media campaigns. It also gives creators a way to explore different visual approaches during the planning stage before refining the selected direction.
For businesses producing content across multiple channels, AI-assisted video generation can help reduce the effort required to develop initial concepts. Generated material can then be reviewed and edited to align with campaign objectives, brand guidelines, and platform requirements.
Image Generation Helps Develop Marketing Concepts
Visual assets influence how products, services, and campaigns are presented to audiences. Developing suitable imagery often involves several rounds of brainstorming and creative testing before a final direction is selected.
CapCut’s Seedream AI image generator enables users to create images from text prompts. The tool can support concept drafts, campaign planning, and experimentation with different visual styles.
For example, a seasonal marketing campaign may require several approaches to backgrounds, compositions, and visual themes. AI-generated drafts can help illustrate those options before resources are committed to final production.
CapCut’s GPT Image 2 provides another option for generating images from natural language instructions. The feature can support the development of promotional graphics, campaign imagery, and other visual assets.
These tools help shorten the early stages of creative development by making it easier to turn written ideas into visual references. Human review remains important to ensure the resulting assets accurately represent the product and meet the campaign’s requirements.
Image Editing Simplifies Asset Preparation
AI image generation is only one part of preparing content for publication. Existing photographs and graphics often need adjustments before they can be used across marketing channels.
CapCut’s AI background removal tool helps separate subjects from their original backgrounds. This can be useful when preparing product images, promotional graphics, and other assets that require a different visual setting.
The AI Image Extender addresses the challenge of adapting images to different layouts. By generating content beyond an image’s original boundaries, the tool can help users adjust compositions for different formats without relying entirely on cropping or stretching.
These capabilities can support the preparation of visuals for social media posts, website banners, digital advertisements, and product promotions. They also provide options for repurposing existing creative assets instead of producing entirely new images for every placement.
AI Audio and Photo Animation Expand Creative Options
Marketing content often combines visuals, movement, and sound to communicate a message. Producing these elements separately can add complexity to the creative process.
CapCut’s SeedMusic AI audio generator supports AI-assisted music creation based on creative prompts. Generated music can be used as a starting point for videos, promotional campaigns, and other multimedia projects, subject to appropriate review and usage requirements.
The platform’s Photo-to-3D tool offers another way to adapt still images into more dynamic visual content. This capability can help transform existing photography into animated presentations for product showcases, social media, and digital promotions.
By supporting audio creation and image animation alongside video and image tools, CapCut provides additional options for developing varied marketing materials.
A Connected Workflow for Marketing Content
CapCut’s collection of AI-powered features supports several stages of campaign production within one creative environment. A project could begin with concept images generated through Seedream, followed by visual development with GPT Image 2. Background removal and image expansion can then help prepare assets for different placements.
Selected visuals can be incorporated into video projects using Seedance 2.0, while SeedMusic offers an option for developing accompanying audio. Photo-to-3D can provide another format for repurposing existing images.
Not every campaign requires all these capabilities. Their practical value depends on the content format, production requirements, and intended audience. Reviewing generated assets for accuracy, visual consistency, and suitability remains essential before publication.
Better Business Advice’s recognition of CapCut reflects the growing role of AI-assisted production in digital marketing. As businesses continue to develop content for multiple channels, tools that support video creation, image generation, editing, and multimedia production can help simplify creative workflows while leaving room for human direction and quality control.
The full article can be read at the Better Business Advice website.
About CapCut
CapCut is an AI-powered photo and video editing platform designed to make high-quality video creation accessible across devices. The platform supports creators, businesses, and everyday users with tools for video editing, AI video generation, captions, templates, audio, and visual editing. CapCut is available across mobile, web, desktop, and iPad experiences, helping users create, edit, and prepare video content for social media, marketing, education, and personal projects.
About Better Business Advice: Better Business Advice covers the news and strategies driving modern business success. The information provided by Better Business Advice does not, and is not intended to, constitute legal advice; instead, all information, content, and materials are for general informational purposes only. As an affiliate, Better Business Advice may earn commissions from services mentioned in the links provided.
View original content:https://www.prnewswire.com/news-releases/best-ai-tools-for-marketing-content-2026-capcut-recognized-for-faster-ai-powered-video-and-image-creation-by-better-business-advice-302918030.html
SOURCE BetterBusinessAdvice.com
Technology
Bio-Thera Announces Promising Clinical Data for BAT8008 in Combination with BAT1308 in First-Line Non-Small Cell Lung Cancer at ESMO 2026
Published
14 minutes agoon
October 24, 2026By
GUANGZHOU, China, Oct. 24, 2026 /PRNewswire/ — Bio-Thera Solutions, Ltd. (688177.SH), a commercial-stage biopharmaceutical company developing innovative therapies and biosimilars, today announced the presentation of clinical data for BAT8008, a TROP2-targeted antibody-drug conjugate (ADC), in combination with BAT1308, an anti-PD-1 monoclonal antibody, at the 2026 European Society for Medical Oncology (ESMO) Congress. Professor Shaodong Hong of Sun Yat-sen University Cancer Center delivered a rapid oral presentation highlighting results from the combination regimen in patients with non-small cell lung cancer (NSCLC). Further details are available on Bio-Thera’s official website.
In the first-line, mutation-negative NSCLC population (N=104), treatment with BAT8008 in combination with BAT1308 achieved an objective response rate (ORR) of 61.2% and a median progression-free survival (PFS) of 12.42 months. In the non-squamous NSCLC subgroup, the ORR was 65.2%, while median PFS had not yet been reached at the time of analysis. The combination demonstrated a manageable safety profile consistent with the known safety characteristics of the individual agents, with no new safety signals identified.
“We are very encouraged by these Phase 2 results evaluating BAT8008 in combination with BAT1308 as a first-line treatment for advanced non-small cell lung cancer”, said Shengfeng Li, CEO of Bio-Thera Solutions. “The findings support the potential of this combination approach in First Line NSCLC and reinforce our commitment to advancing innovative oncology therapies for patients with significant unmet medical needs.”
Lung cancer remains a major global health challenge, and NSCLC accounts for the majority of lung cancer cases. Patients with advanced NSCLC who lack actionable genomic alterations continue to face significant treatment challenges, despite advances in immunotherapy and chemoimmunotherapy. New treatment strategies that can improve clinical outcomes while maintaining a manageable safety profile remain an important area of oncology research.
TROP2-targeted ADCs combine tumor-directed delivery of cytotoxic payloads with the potential to modulate the tumor microenvironment. When combined with PD-1 blockade, this approach may offer complementary mechanisms of action, providing a rationale for clinical investigation in NSCLC. The clinical findings presented at ESMO 2026 support further evaluation of BAT8008 in combination with BAT1308 as a potential treatment option for patients with NSCLC.
About Bio-Thera Solutions:
Bio-Thera Solutions, Ltd., a leading innovative, global biopharmaceutical company in Guangzhou, China, is dedicated to researching and developing novel therapeutics for the treatment of cancer, autoimmune, cardiovascular, eye diseases, and other severe unmet medical needs, as well as biosimilars for existing, branded biologics to treat a range of cancer and autoimmune diseases. As a leader in next generation antibody discovery and engineering, the company has advanced multiple candidates into late-stage development, including six approved products: QLETLI® (adalimumab) and BETAGRIN® (bevifibatide citrate) Injection in China, STARJEMZA® (ustekinumab) in the US and USYMRO® (ustekinumab) in the EU, TOFIDENCE®/BAT1806 (tocilizumab) and AVZIVI® (bevacizumab-tnjn) in the US and in the EU, a/k/a POBEVCY® in China, and GOTENFIA® (golimumab) in the EU and IMMGOLIS™ (golimumab-sldi) in the US. In addition, the company has more than 20 promising candidates in clinical trials, focusing on immuno-oncology in the post-PD-1 era and targeted therapies such as antibody-drug conjugates (ADCs). For more information, please visit www.bio-thera.com/en/ or follow us on X (@bio_thera_sol) and WeChat (Bio-Thera).
Bio-Thera Cautionary Note Regarding Forward-Looking Statements
This news release contains certain forward-looking statements relating to BAT8008, BAT1308 or the product pipelines in general of Bio-Thera Solutions. Readers are strongly cautioned that reliance on any forward-looking statements involves known and unknown risks and uncertainties. The forward-looking statements include, among others, those containing “could,” “may,” “should,” “will,” “would,” “anticipate,” “believe,” “plan,” “promising,” “potentially,” or similar expressions. They reflect the company’s current views with respect to future events that are based on what the company believes are reasonable assumptions in view of information currently available to Bio-Thera Solutions, and are not a guarantee of future performance or developments. Actual results and events may differ materially from information contained in the forward-looking statements as a result of a number of factors, including, but not limited to, risks and uncertainties inherent in pharmaceutical research and development, such as the uncertainties of pre-clinical and clinical studies. Other risks and uncertainties include challenges in obtaining regulatory approvals, manufacturing, marketing, competition, intellectual property, product efficacy or safety, changes in global healthcare situation, changes in the company’s financial conditions, and changes to applicable laws and regulations, etc. Forward-looking statements contained herein are made only as of the date of their initial publication. Unless required by laws or regulations, Bio-Thera Solutions undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, changes in the company’s views or otherwise.
Bio-Thera Contact:
Bert E. Thomas IV
Phone: +1.410.627.1734
Email: bethomas@bio-thera.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/bio-thera-announces-promising-clinical-data-for-bat8008-in-combination-with-bat1308-in-first-line-non-small-cell-lung-cancer-at-esmo-2026-302918492.html
SOURCE Bio-Thera Solutions, Ltd
Technology
ASTRI Showcases Pioneering Technologies at InnoCarnival 2026
Published
1 hour agoon
October 24, 2026By
Driving Technology Adoption, Shaping a Vision for the Future
HONG KONG, Oct. 24, 2026 /PRNewswire/ — The Hong Kong Applied Science and Technology Research Institute (ASTRI) is proud to present a range of cutting-edge technologies and practical solutions at this year’s InnoCarnival, spanning communications technology, smart cities, IoT sensing, and renewable energy and energy storage. ASTRI’s innovations address urban development needs and everyday applications, driving diversity in the innovation and technology (I&T) sector.
Organised by the Innovation and Technology Commission of the Hong Kong SAR Government, the InnoCarnival 2026 runs from today through 1 November at Hong Kong Science Park (HKSP) with the theme of “Lead with I&T, Dream to Fly High “, offering the public an opportunity to experience the transformative power and I&T vibrancy.
Ir Dr Ted Suen, Chief Executive Officer of ASTRI, stated: “Innovation is not just about breakthroughs in the lab – it’s about putting technology into practice, empowering industries, and benefiting society as a whole. At ASTRI, we align closely with the government’s priorities in advancing AI development and accelerating new industrialisation. Through our participation in the InnoCarnival, we showcase various state-of-the-art technologies, some of which have been co-developed with industry partners and are already in commercial rollout. These innovations demonstrate the tangible benefits of technology in daily life and inspire the public to explore their curiosity about science and innovation.”
He highlighted the InnoCarnival as a key platform to bridge the I&T community with the public. “This annual landmark event motivates young people to explore their potential and encourages them to pursue careers in Hong Kong’s growing I&T sector,” he added.
ASTRI’s booth (A08), located at the HKSP’s Atrium Link, features interactive games powered by its groundbreaking technologies “5G-SAT Link” and “Omniguard-All-Weather Multispectral Surveillance System” technologies. Visitors can also explore other advanced solutions on display, including the dual-purpose “SafeStop Dual-purpose Impact Dissipation Bollard”, the “Hybrid-Powered Asset Tracker”, and the award-winning “NIR Secure Anti-Counterfeit Solutions”, which received gold award at the prestigious Edison Awards.
1. 5G-SAT Link
ASTRI’s “5G-SAT Link” technology delivers seamless, comprehensive communications coverage—even in remote areas, emergency scenarios where infrastructure is compromised, or at sea and in the air.
2. Omniguard: All-Weather Multispectral Surveillance System
The “Omniguard” is equipped with exceptional fog penetration capabilities, superior contrast, and crystal-clear signal quality. Leveraging its advanced shortwave and longwave infrared sensors, the system can even detect non-metallic vessels that are difficult for radar systems to identify in harsh coastal environments.
3. SafeStop Dual-purpose Impact Dissipation Bollard
Developed by ASTRI, the “SafeStop Bollard” features a unique material design inspired by the retractable claw structure of cats. Its 3D tension-expansion composition allows it to effectively dissipate kinetic energy from moving vehicles, providing dual protection by blocking vehicles while minimising potential harm to occupants. Certified to meet international crash-test standards, the bollard’s shallow foundation design makes it ideal for fast and efficient installation in high-traffic urban locations.
4. Hybrid-Powered Asset Tracker
The “Hybrid-Powered Asset Tracker” enables efficient, real-time management of airport equipment such as baggage carts over extended periods. Supported by the Airport Authority Hong Kong, the tracker is compatible with airport wireless networks and utilises automatic Bluetooth-GPS switching for seamless indoor and outdoor location updates. With a long-lasting battery combined with an efficient, low-light solar panel, the tracker extends its lifespan from under two years to five years.
5. NIR Secure Anti-Counterfeit Solutions
The “NIR Secure Anti-Counterfeit Solutions” offer an innovative authentication system by embedding covert near-infrared (NIR) absorbing materials into product packaging. Users can verify product authenticity instantly using a smartphone, paired with an NIR reader and mobile app. Highly scalable and robust, this solution combats counterfeit goods while preserving the original product design and production workflow. Co-developed with Zhuhai Print-Rite New Materials Corporation Ltd., this technology sets a new benchmark in secure authentication.
Photos Download: https://bit.ly/4iguifh
About ASTRI
Founded in 2000 by the HKSAR Government, Hong Kong Applied Science and Technology Research Institute (ASTRI) is the city’s largest government-funded R&D centre. Committed to transforming high-impact research into practical innovations, ASTRI drives market-driven, interdisciplinary advancements across sectors, including Smart City, FinTech, Digital Health and Life Sciences, New Industrialisation and Intelligent Manufacturing, Application-Specific Integrated Circuits (ASIC) and Advanced Electronics, New Energy and Energy Storage, and Green and ESG Technologies. Following its merger with the Nano and Advanced Materials Institute, ASTRI has further strengthened its capabilities, with over 1,500 patents and 2,200 successful cases of technology transfer. Recognised with numerous international awards, ASTRI continues to nurture top I&T talent and foster collaborations among the I&T ecosystem, contributing to Hong Kong’s high-value economic development. For more information, please visit: https://www.astri.org
View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/astri-showcases-pioneering-technologies-at-innocarnival-2026-302918617.html
SOURCE Hong Kong Applied Science and Technology Research Institute (ASTRI)
Best AI Tools for Marketing Content (2026): CapCut Recognized for Faster AI-Powered Video and Image Creation by Better Business Advice
Bio-Thera Announces Promising Clinical Data for BAT8008 in Combination with BAT1308 in First-Line Non-Small Cell Lung Cancer at ESMO 2026
ASTRI Showcases Pioneering Technologies at InnoCarnival 2026
Send Rakhi to UK swiftly with UK Gifts Portal
Whiteboard Series with NEAR | Ep: 45 Joel Thorstensson from ceramic.network
Nullmax and Renesas Forge Strategic Partnership to Deliver Competitive ADAS Solutions for the Global Market
Why You Should Build on #NEAR – Co-founder Illia Polosukhin at CV Labs
Whiteboard Series with NEAR | Ep: 45 Joel Thorstensson from ceramic.network
NEAR End of Year Town Hall 2021: The Open Web World, MetaBUILD 2 Hackathon and 2021 recap
Trending
-
Coin Market5 days agoWorld Liberty’s USD1 stablecoin sheds $400M in market cap in two weeks
-
Technology5 days agoEnciso Systems Joins SOLAIYA / GARDANT GLOBAL Team to Provide IT Services on NASA SEWP VI Contract
-
Technology4 days agoSophont Launches Holon-S1 to Reveal Tumor Biology from Routine Pathology Slides
-
Technology5 days agoOppFi Announces its Third Quarter 2026 Earnings Conference Call
-
Technology5 days agoEqvista Launches Company-Sponsored Tender Offers, Expanding Private Market Liquidity Capabilities
-
Technology4 days agoNC AI Officially Releases VARCO Sound, the Generative AI Sound Production Service
-
Technology5 days agoTomoIQ Launches Money Finder at Money20/20, Bringing Agentic Finance to Mainstream Consumers
-
Technology5 days agoTomoIQ Launches Money Finder at Money20/20, Bringing Agentic Finance to Mainstream Consumers
